Log in with your email address username.


Attention doctorportal newsletter subscribers,

After December 2018, we will be moving elements from the doctorportal newsletter to MJA InSight newsletter and rebranding it to Insight+. If you’d like to continue to receive a newsletter covering the latest on research and perspectives in the medical industry, please subscribe to the Insight+ newsletter here.

As of January 2019, we will no longer be sending out the doctorportal email newsletter. The final issue of this newsletter will be distributed on 13 December 2018. Articles from this issue will be available to view online until 31 December 2018.

[Correspondence] Whole brain radiotherapy for non-small cell lung cancer

We disagree with the conclusion that whole brain radiotherapy (WBRT) has little additional clinical benefit for patients with non-small cell lung cancer with brain metastases, as reported by Paula Mulvenna and colleagues in the QUARTZ trial.1 Our objection is not only attributed to their study failing to reach the predesigned non-inferiority margin, but more importantly, the difference between two groups being partly erased in at least two aspects of design and data analysis.